Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Market Analysis
Despite progress, tools and platforms for biomarker discovery face numerous challenges
January 29th, 2007
Biomarkers represent one of the most anticipated healthcare concepts since the monoclonal antibody. Anticipated applications for biomarkers include drug discovery and lead optimization, preclinical and clinical development, patient diagnostics, toxicity testing, targeted therapeutics, and treatment tracking and prognostics. But before this potential can be fully realized, numerous challenges remain to be solved. Single biomarkers are no longer considered adequate for most anticipated applications - multiple protein panels are the new paradigm. Because of variations in sample complexity, the approach to biomarker discovery will continue to be highly...
Source: Biotech Business Week (2007-01-29)
|
